Gene Therapy Specialist Kriya Raises $313M (Bio Space)
UF startup Kriya is advancing a host of gene therapies for a wide variety of chronic diseases, including geographic atrophy, trigeminal neuralgia and type 1 diabetes.
UF Health-Led Guidelines Call for Widespread Type 1 Diabetes Screening in Children
UF researcher led an international team of Type 1 diabetes experts who developed new treatment guidelines emphasizing wider screening for the disease among children and adolescents in the general population before symptoms arise.
UF Health Researchers Propose an Update to Type 1 Diabetes Staging System
UF researchers have called for an update to the Type 1 diabetes staging system, urging the development of a more precise risk assessment method to reflect rapid advancements in science and medicine.
Diabetes Detectives
University of Florida aims to improve the lives of millions with diabetes through its clinical and research programs and is globally recognized for its efforts.
First Type 1 Diabetes Patient Enrolled in Rise Therapeutics’ Latest Clinical Trial
Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, announced it has enrolled its first patient in its R-5280 placebo-controlled, blinded, Phase 1b type 1 diabetes clinical trial.
UF Health Shands Children’s Hospital Nationally Ranked in Four Specialties
University of Florida Health Shands Children’s Hospital’s diabetes and endocrinology program is now ranked among the nation’s top 10 by U.S. News & World Report. It is the highest ranking ever for the program, which is joined in the standings by three other UF Health pediatric medical specialties, according to the 2023-24 Best Children’s Hospital rankings.
UF Doctor Receives Distinguished Award for ‘Groundbreaking’ Work on Type 1 Diabetes
Director of the University of Florida’s Diabetes Institute Dr. Mark Atkinson has received a major science award for his groundbreaking research on Type 1 diabetes.
Inspira Awarded $1.98M NIH Grant for Diabetes Therapy
Inspira Therapeutics was awarded a $1.98 million NIH grant to develop its polymeric biomaterial-based tolerogenic treatment for type 1 diabetes.
UF Diabetes Institute Director Receives International Acclaim for Groundbreaking Research
The director of the University of Florida Diabetes Institute has been awarded the 2019 Jacobæus Prize, one of the top international honors in the field of endocrinology and metabolism, for his contributions to groundbreaking Type 1 diabetes research. Mark Atkinson, Ph.D., a professor in the UF College of Medicine’s departments of pathology and pediatrics, received […]
Genetic Risk for Autoimmunity May Be Linked to Differences in Gut Microbiome
University of Florida researchers, Eric W. Triplett, Ph.D., Desmond A. Schatz, M.D., and Mark A. Atkinson, Ph.D. along with Linköping University researchers in Sweden found that the genetic risk for developing type 1 diabetes autoimmunity is associated with distinct changes in the gut microbiome. To arrive at their findings, the researchers used the ABIS (All […]